Cardio Diagnostics Holdings Inc.
Performance History
| Key Stats | |
|---|---|
| Open | $2.35 |
| Prev. Close | $2.39 |
| EPS | -0.80 |
| Dividend | $0.00 |
| Next Earnings Date | Aug 14, 2023 |
| Dividend Yield % | - |
| Market Cap | $38.25M |
| PE Ratio | - |
| low | high | |
|---|---|---|
| Day Range | 2.00 | 2.36 |
| 52 Week Range | 0.17 | 8.50 |
| Ratios | |
|---|---|
| P/B Ratio | 19.59 |
| Revenue | - |
| Operating M. % | -14,398.71% |
| Earnings | -$9.36M |
| Earnings Growth % | - |
| EBITDA Margin % | - |
| ROE % | -157.94% |
| EPS | -0.80 |
Score Breakdown
All Score (54 / 100) is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.
| CDIO | Market | |
|---|---|---|
| Value | 53 | 42 |
| Quality | 40 | 46 |
| Ownership | 23 | 39 |
| Growth | 62 | 44 |
| Dividends | - | 32 |
All Score (54 / 100) is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.
Financial Forecast
AI Price Prediction
Analyst Ratings
Correlated Companies
About Cardio Diagnostics Holdings Inc. (CDIO)
Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.
- ISN
- -
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Meeshanthini V. Dogan Ph.D.
- Headquarters
- Chicago
- Employees
- 7
Keep an eye on Cardio Diagnostics Holdings Inc.
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
News
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.